Search results
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Zacks· 5 days agoThe first-quarter earnings season has come to an end for large drug and biotech companies, with Bayer reporting its results earlier this week. Per the Zacks ...
The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Costco and Koss
Zacks via Yahoo Finance· 14 hours agoThe company’s revenue growth is being driven by higher demand for drugs like Mounjaro...Taltz and...
U.S. House Committee on Oversight and Accountability Democrats Ranking Member Raskin Urges Insurers...
Sierra Sun Times· 2 days agoWashington, D.C. - On Thursday, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, sent letters to the five of the largest health insurers and four of the largest ...
DEA: Local drug case one of region’s biggest
The Missourian· 3 days agoA drug manufacturing scheme run by a Sullivan man sentenced earlier this month was one of the country’s largest counterfeit Xanax operations, according...
Dow Jones Today: Tech Lifts Nasdaq to Record; Dow Slips From 40K
Investopedia· 6 hours agoPalo Alto Networks (PANW) is set to report earnings for its fiscal third quarter after the bell on...
AbbVie prevails in suit alleging payoffs to generic manufacturers
Crain s Chicago Business· 3 days agoA U.S. appeals court has dismissed a complaint against AbbVie and its subsidiary Allergan, which were accused of using "unlawful 'reverse' settlement payments" to keep generic
FTC warns pharma companies it means business with its Orange Book listing policy | JD Supra
JD Supra· 6 days agoLast September, the Federal Trade Commission (FTC) promulgated a “policy statement” entitled “Statement Concerning Brand Drug Manufacturers’ Improper Listing of Patents in ...
Prescription benefit manager move into drugmaking draws scrutiny - Marketplace
Marketplace· 6 days agoIf you’ve filled a prescription in the past decade, you’re probably familiar with at least one...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks· 5 days agoFree Report) announced that the FDA has granted accelerated approval to the label expansion of chimeric antigen receptor (CAR) T cell therapy Breyanzi (lisocabtagene maraleucel; liso-cel). The ...
Raskin presses insurers, PBMs on free contraception coverage
The Hill via Yahoo News· 4 days agoThe top Democrat on the House Oversight and Accountability Committee wants to know how the country’s...